Abstract:Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) comprise a heterogeneous group of neoplasms, which derive from cells of the diffuse neuroendocrine system that specializes in producing hormones and neuropeptides and arise in most cases sporadically and, to a lesser extent, in the context of complex genetic syndromes. Furthermore, they are primarily nonfunctioning, while, in the case of insulinomas, gastrinomas, glucagonomas, vipomas, and somatostatinomas, they produce hormones responsible for clinical syndromes. The GEP-NEN tumor grade and cell differentiation may result in different clinical behaviors and prognoses, with grade one (G1) and grade two (G2) neuroendocrine tumors showing a more favorable outcome than grade three (G3) NET and neuroendocrine carcinoma. Two critical issues should be considered in the NEN diagnostic workup: first, the need to identify the presence of the tumor, and, second, to define the primary site and evaluate regional and distant metastases. Indeed, the primary site, stage, grade, and function are prognostic factors that the radiologist should evaluate to guide prognosis and management. The correct diagnostic management of the patient includes a combination of morphological and functional evaluations. Concerning morphological evaluations, according to the consensus guidelines of the European Neuroendocrine Tumor Society (ENETS), computed tomography (CT) with a contrast medium is recommended. Contrast-enhanced magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI), is usually indicated for use to evaluate the liver, pancreas, brain, and bones. Ultrasonography (US) is often helpful in the initial diagnosis of liver metastases, and contrast-enhanced ultrasound (CEUS) can solve problems in characterizing the liver, as this tool can guide the biopsy of liver lesions. In addition, intraoperative ultrasound is an effective tool during surgical procedures. Positron emission tomography (PET-CT) with FDG for nonfunctioning lesions and somatostatin analogs for functional lesions are very useful for identifying and evaluating metabolic receptors. The detection of heterogeneity in somatostatin receptor (SSTR) expression is also crucial for treatment decision making. In this narrative review, we have described the role of morphological and functional imaging tools in the assessment of GEP-NENs according to current major guidelines.

Diagnosis and Treatment of Gastrointestinal Neuroendocrine Neoplasm in the Multidisciplinary Team Model

[Implementation of Multidisciplinary Team in the Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasm].

Role of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Renewal of ideas and focus of gastroenteropancreatic neuroendocrine neoplasm

Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach

[Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors]

Early diagnosis and treatment of gastrointestinal neuroendocrine tumors.

Modern strategy for the management of gastroenteropancreatic neuroendocrine neoplasm liver metastases

Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives

[Gastroenteropancreatic Neuroendocrine Tumor Microenvironment and Related Therapy].

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Role of Advanced Gastrointestinal Endoscopy in the Comprehensive Management of Neuroendocrine Neoplasms

Advances and Pathological Diagnostic Standard of Gastroenteropancreatic Neuroendocrine Neoplasms

Gastroenteropancreatic Neuroendocrine Neoplasms：concepts and Related Issues

Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists

Analysis of The Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasm in 70 Cases

Progress of Drug Treatment for Gastrointestinal Neuroendocrine Neoplasm

The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors

[The Diagnosis and Treatment of Pancreatic Neuroendocrine Neoplasms].

Clinicopathological Features And Prognostic Factors Of Colorectal Neuroendocrine Neoplasms

[Advances in Immunotherapy for Neuroendocrine Neoplasms].